Publications

“An Apparent Binary Choice in Biochemistry: Mutual Reactivity Implies Life Chooses Thiols or Nitrogen-Sulfur Bonds, but Not Both” Janusz J. Petkowski, William Bains, and Sara Seager Astrobiology 19, 4 (March 2019): p. 579-613 doi 10.1089/AST.2018.1831 ©2019

To read the full article click here

"Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice ", Crowe, M.S., Leishman, E., Banks, M.L., Gujjar, R., Mahadevan, A., Bradshaw, H.B., & Kinsey, S.G. ; British Journal of Pharmacology. , 2015, 172(7),1700-1712.

"Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer ", Murase R, Kawamura R, Singer E, Pakdel A, Sarma P, Judkins J, Elwakeel E, Dayal S, Amere M, Gujjar R, Mahadevan A, Desprez P and McAllister S.D. ; British Journal of Pharmacology. , 2014, 171(19),4464-4477.

"The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model ", Ghosh, S.; Wise, L. E.; Chen, Y.; Gujjar, R.; Mahadevan, A.; Cravatt, B. F.; Lichtman, A. ; Life Sci. , 2013, 92(8-9),498-505.

"Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice", Wiley, J. L.; Marusich, J. A.; Zhang, Y.; Fulp, A.; Maitra, R.; Thomas, B. F.; Mahadevan, A. ; Eur. J. Pharmacol. , 2012, 695,62.

"Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke", Zhang, M.; Mahadevan, A.; Amere, M.; Li, H.; Ganea, D.; Tuma, R. F. ; Translational Stroke research, 2012, 3(3), 348-356.

"Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions", Ramirez, S. H.; Hasko, J.; Skuba, A.; Fan, S.; Dykstra, H.; McCormick, R.; Reichenbach, N.; Krizbai, I.; Mahadevan, A.; Zhang, M.; Tuma, R.; Son, Y. J.; Persidsky, Y. ; J. Neurosci., 2012, 32(12), 4004-4016.

"3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism", Wiley, J. L.; Selley, D. E.; Wang, P.; Kottani, R.; Gadthula, S.; Mahadevan, A.; J. Pharmacol. Exper.Ther., 2012, 340(2), 433.